Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

Johnson & Johnson to Begin Testing Ebola Vaccine in January

online.wsj.com — Johnson & Johnson said it would begin testing an Ebola-virus vaccine in humans in January and could have 250,000 doses available in May, if health authorities deem it safe and promising enough to distribute more broadly. There is no approved vaccine guarding against the deadly Ebola virus.

Eli Lilly CEO Lechleiter Sees Light After a Difficult Year

online.wsj.com — Eli Lilly & Co. is deep into what Chief Executive John C. Lechleiter calls the "toughest year" in the drug maker's 138-year history. Revenue at Lilly has plunged because of generic competition that followed patent expirations for several of its top-selling drugs, including the antidepressant Cymbalta.

Better Late Than Never: CMS Improves The Doctor Payment Website

blogs.wsj.com — Late Friday, the Centers for Medicare and Medicaid services issued a so-called beta release of an online search tool on its Open Payments website. The tool lets you search by a physician's name, location or specialty, as well as by the names of teaching hospital and companies.

Ebola Drug Race Ramps Up in Earnest

online.wsj.com — When it started developing an Ebola drug in 2010, Tekmira Pharmaceuticals Corp. wasn't counting on finding infected humans to test it in. Instead, the company planned to seek approval based on animal studies, which regulators sometimes allow.

Gates Foundation Asks CSL to Explore Plasma Treatment for Ebola

online.wsj.com — CSL Ltd., an Australian maker of blood-plasma therapeutics, says it is exploring whether it can develop a plasma product to treat Ebola. Chief Executive Paul Perreault said he formed a small team to assess the feasibility at the request of the Bill & Melinda Gates Foundation a few weeks ago.

Chimerix to Conduct Ebola Drug Trial

Specialist Hospitals Face Challenges in Handling Ebola Outbreak

online.wsj.com — As the Ebola epidemic in West Africa continues to expand, more cases could appear and require treatment at U.S. hospitals far from the specialist centers that have handled most cases so far. But the challenges even these specialist centers have encountered show the steep learning curve all hospitals are facing.

Ebola Treatment Maker Takes New Steps to Increase Production

online.wsj.com — Mapp Biopharmaceutical Inc. is taking new steps to expand production of ZMapp, the experimental Ebola treatment that was provided to several infected patients before supplies ran out in August. In a statement, the tiny San Diego, Calif., company said it is attempting to improve production yields at its current contract manufacturer, and is also seeking to expand production to an additional facility.

Dallas Ebola Patient Receiving Chimerix Experimental Drug

Doctors, Companies Say Physician Payment Database Contains Errors

More Articles →
Oct 22, 2014

US companies get 9% of foreign profits via tax haven Luxembourg, but only 0.1% of foreign workforce there: on.wsj.com/ZN6Xsb via @WSJ

Oct 20, 2014

RT @jonathanrockoff: $LLY CEO Lechleiter: U.S. corp taxes need changing "but we see v. little impetus right now coming out of Washington." on.wsj.com/1wi99Cv

Oct 20, 2014

Fujifilm to boost production of Antiflu drug for Ebola treatment on.wsj.com/1wjNw4W via @WSJ

Oct 20, 2014

Eli Lilly CEO Lechleiter sees light after a difficult year on.wsj.com/1wi99Cv via @WSJ $LLY

Oct 20, 2014

RT @TomBurtonWSJ: Post-Doc Project: Dr. Sullivan Makes #Ebola Vaccine at #NIH. "I don't like animal studies." My @WSJ story. on.wsj.com/1rUCwX6 via @WSJ

Oct 16, 2014

When love breaks down... Collapse of AbbVie-Shire Deal Leaves Scars on.wsj.com/1ze9xri via @WSJ

Oct 15, 2014

RT @pharmalot: Between Friends: a former Merck analyst is charged with insider trading.. and the SEC lawsuit is here.. blogs.wsj.com/pharmalot/2014… #pharma $MRK

Oct 13, 2014

Among #Ebola challenges facing US hospitals: finding willing specimen couriers: on.wsj.com/1w2p0VG via @WSJ @betswrites

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.

Share This Profile